Form 4: Madrigal Pharmaceuticals Director Richard S. Levy Reports Stock Option Exercise and Sale
SEC Form 4 Filing
Director Richard S. Levy exercised stock options and sold shares of Madrigal Pharmaceuticals on April 10, 2025.
Summary
- On April 10, 2025, Richard S. Levy, a director of Madrigal Pharmaceuticals, exercised stock options to acquire 9,470 shares of common stock at a price of $65.06 per share.
- Simultaneously, Levy disposed of 20,482 shares.
- Following these transactions, Levy directly owns 0 derivative securities and 20,482 shares of Madrigal Pharmaceuticals common stock.
Sentiment
Score: 5
Explanation: This is a neutral disclosure of insider trading activity. The exercise of options and sale of shares could be for various reasons and doesn't necessarily indicate a positive or negative outlook.
Industry Context
This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. Investors often monitor these filings for insights into management's perspective on the company's stock.
Stakeholder Impact
- The transaction may have a minor impact on shareholders due to the change in ownership.
Key Dates
| Date | Description |
|---|---|
| 04/10/2025 | Date of stock option exercise and share disposal |
| 04/11/2025 | Date of signature on the Form 4 filing |
| 06/16/2025 | Expiration date of the stock options |
Keywords
Form 4, Madrigal Pharmaceuticals, MDGL, Richard S. Levy, Stock Options, Director, Insider Trading
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.